AP Technologies acquires Blueacre Technology
Analysis based on 6 articles · First reported May 19, 2026 · Last updated May 22, 2026
The acquisition of Blueacre Technology>>> by AP Technologies>>> is expected to positively impact the medical device manufacturing market by creating a more integrated supplier for hybrid catheter and delivery systems. This could lead to increased efficiency and innovation in minimally invasive technologies, benefiting OEMs and potentially driving growth in the sector.
AP Technologies>>>, a Singapore-headquartered contract manufacturer of catheters and medical tubing, announced the acquisition of Blueacre Technology>>>, an Republic of Ireland>>>-based specialist in laser micromachining and nitinol processing for the medical device industry. This strategic move expands AP Technologies>>>'s vertically integrated catheter platform to include advanced metallic component processing, establishing its first European operation in Republic of Ireland>>>'s medtech corridor. David Gillen>>>, founder of Blueacre Technology>>>, will continue to lead the Dundalk facility and join AP Technologies>>>'s leadership team. The acquisition aims to offer OEM partners a single supplier for hybrid catheter and delivery system programs, combining polymeric and metallic manufacturing capabilities.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard